To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

March 4, 2024

2024 National HOPE Award Nominations Now Open

EBCI logo white

Disease Education, Awareness & Outreach Campaign Presented by Novocure

Every May for over a decade, the End Brain Cancer Initiative (EBCI) has presented the National HOPE Award to a brain cancer patient who inspires us with their courage and hope in the face of this devastating disease. EBCI established the National HOPE Award to highlight exceptional people with brain cancer and their inspiring stories. The deadline for submitting nominations is April 17, 2024.

Photo of Jenn Ortiz and Dellann
Dellann Elliott Mydland (EBCI CEO & President) with Jenn Ortiz (2023 National HOPE Award Runner-up)
Jenn Ortiz and family
Jenn Ortiz (2023 National HOPE Award Runner-up) with her family

“To me, HOPE is determination. I make HOPE happen,” said Jenn Ortiz, the 2023 National HOPE Award Runner-up who has been battling Glioblastoma (GBM) brain cancer for nearly four years.

Since being nominated last year, Jenn has dedicated herself to advocating for brain cancer patients and inspiring hope in others. “I don’t take NO for an answer. A closed door is just an opportunity, and I encourage those in the industry to take the same approach," she said.

This disease education, awareness and outreach campaign is made possible by the presenting sponsor Novocure and other patient disease education sponsors. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Learn more at

Nominate a brain cancer patient for the National HOPE Award today.

Dellann Secondary Headshot 2024

Dellann Elliott Mydland
The End Brain Cancer Initiative
President & CEO

HOPE 22yrs

Hand holding cell phone displaying app
  • Trials & Studies
  • New Research
  • Patient & Caregiver Resources
  • Disease Information
  • Meetings & Events
  • And More!

Scan or click the QR code to download the App now!

Sponsor logos


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram